Resistin and Insulin Resistance: A Link Between Inflammation and Hepatocarcinogenesis
Open Access
- 4 November 2015
- journal article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 16 (16), 7139-7142
- https://doi.org/10.7314/apjcp.2015.16.16.7139
Abstract
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third leading cause of cancer related death overall. The role of insulin resistance in the development of HCC associated with chronic HCV infection has not been established. Resistin is a polypeptide hormone belonging to the adipokine family which could contribute to tumorigenesis and angiogenesis. Our aim was to study serum resistin and insulin resistance as risk factors for HCC in HCV cirrhotic patients. This prospective case controlled study included 100 patients with HCV related liver cirrhosis and HCC, 100 patients with HCV related liver cirrhosis without HCC and 50 apparently healthy participants as controls. For all subjects, liver profile, serologic markers for viral hepatitis, lipid profile, alpha-fetoprotein level (AFP), homeostasis model assessment (HOMA) were examined along with resistin. HCC patients had higher mean values of HOMA-IR and resistin than cirrhotic patients and the control subjects (p 12 ng/ml and HOMA >4 being 1.6 times more likely to have HCC. HOMA and serum resistin allow for early identification of patients with cirrhosis who are at substantially increased risk of HCC. HOMA and serum resistin could represent novel markers to identify HCV cirrhotic patients at greater risk of development of HCC.Keywords
This publication has 22 references indexed in Scilit:
- Serum resistin: A biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parametersClinical Biochemistry, 2013
- Hepatitis C virus induced insulin resistance impairs response to anti viral therapyWorld Journal of Gastroenterology, 2012
- Insulin resistance and hepatitis C: an evolving storyGut, 2011
- Hyperinsulinemia and risk for hepatocellular carcinoma in patients with chronic liver diseases and Type 2 diabetes mellitusExpert Review of Gastroenterology & Hepatology, 2009
- Resistin as an Intrahepatic Cytokine: Overexpression during Chronic Injury and Induction of Proinflammatory Actions in Hepatic Stellate CellsThe American Journal of Pathology, 2006
- The Metabolic Syndrome: A High-Risk State for Cancer?The American Journal of Pathology, 2006
- Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis CGut, 2005
- An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosisBiochemical Pharmacology, 2004
- New strategies for basal insulin treatment in type 2 diabetes mellitusClinical Therapeutics, 2004
- IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokinesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2002